SERA: כמות מזומנים למניה Sera Prognostics, Inc.

The automation of proteomic research has eliminated human error in diagnostics, which is reflected in the trend of cash per share for Sera Prognostics (SERA). The implementation of a unique blood test to identify risks of preterm birth has strengthened the company's position, while management's current efforts to scale sales through insurance funds are driving the trend. The value of 1.10 shows the current value of the metric.
פילוחי מדדים מקיפים ואנליטיקה עבור Sera Prognostics Inc. (SERA)

This indicator determines the company's liquid reserve divided by the number of shares, serving as a fundamental measure of financial autonomy and capital protection against devaluation. For Sera Prognostics (SERA), cash per share reflects the business's ability to accumulate funds from the sale of pregnancy diagnostic tests, allowing this chart to assess the resilience of the operating model without resorting to expensive debt financing.